Company Directory / Pharmaceuticals
ClosedFor profitPharmaceuticalsSouth San Francisco, CA, United States
Portola Pharmaceuticals
Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.
- Founded
- 2003 23 years ago
- Staff
- 51-100 55 on LinkedIn
- Followers
- 13k on LinkedIn
- Funding
- $1.3B as listed, USD
We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers.… Read all
We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers. We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 55 people list it on LinkedIn.
Age
23 years old.
Reach
No web traffic ranking listed. 12,818 followers on LinkedIn.
What it does
BiopharmaBiotechnologyTherapeuticsBiotechnology / PharmaceuticalThrombosisOncology
Funding, as listed
$1.3B raised in total
- Rounds11
- LatestPost ipo equity, Aug 2019
- Latest amountUSD 258,750,016
- Investors25, 12 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about Portola Pharmaceuticals, field by field. Contact details are held but never shown.
The company
- Name
- Portola Pharmaceuticals
- Type
- For profit
- Status
- Closed
- Founded
- 2003
- Founders
- Charles Homcy, David Phillips
- Industry
- Pharmaceuticals
- Categories
- Biopharma, Biotechnology, Therapeutics
- Specialities
- Biotechnology / Pharmaceutical, Thrombosis, Oncology
Where
- City
- South San Francisco
- Region
- CA
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 55
- LinkedIn followers
- 12,818
Funding, as listed
- Total
- $1,314,100,015 USD
- Rounds
- 11
- Latest round
- Post ipo equity
- Latest round date
- Aug 2019
- Latest amount
- 258,750,016 USD
- Investors
- 25
- Lead investors
- 12
- Stock listing
- NASDAQ:PTLA
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Companies like it
Pharmaceuticals in United States.
PCI Pharma ServicesPhiladelphia · 5001-10000 people · 71k followersAAmneal PharmaceuticalsBridgewater · 5001-10000 people · 225k followersssanofi-aventis U.SBridgewater · 10001+ people
NovavaxGaithersburg · 1001-5000 people · 74k followersRReata PharmaceuticalsPlano · 251-500 people · 23k followersCCatalent Pharma SolutionsSomerset · 5001-10000 people · 291k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.